ROTHBLATT MARTINE A 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 4:30 pm Sale |
2024-09-30 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,194,162 6.800% |
-706,146 (-18.10%) |
Filing |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,900,308 7.800% |
-19,295 (-0.49%) |
Filing |
| 2023-02-02 06:02 am Sale |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,919,603 8.000% |
-198,884 (-4.83%) |
Filing |
| 2022-02-04 4:31 pm Purchase |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 4,118,487 8.500% |
489,001 (+13.47%) |
Filing |
| 2021-03-01 4:30 pm Purchase |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,629,486 7.600% |
3,629,486 (New Position) |
Filing |